The PCPNDT Act and PGT-A Abroad — a plain-English legal guide for Indian patients

1. What the PCPNDT Act actually is

The Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994 — usually abbreviated PCPNDT Act — is Indian legislation enacted to address the skewed sex ratio at birth in India, with the core aim of preventing selective abortion of female foetuses. The Act was amended significantly in 2003 to extend its scope to pre-conception sex selection and to tighten enforcement.

It is administered by the Ministry of Health & Family Welfare, and enforced at the state and district level through Appropriate Authorities and Advisory Committees.

2. What the Act prohibits

In plain terms, the Act makes the following illegal when performed in India:

• The use of pre-natal diagnostic techniques (ultrasound, amniocentesis, chorionic villus sampling) for the purpose of determining the sex of a foetus.
• The use of pre-conception sex-selection techniques (PGD/PGT for sex selection, sperm-sorting methods such as Ericsson and MicroSort) for non-medical sex selection.
• Communicating, by any means, the sex of a foetus to anyone including the pregnant woman.
• Advertising sex-determination or sex-selection services.
• Operating a genetic clinic, laboratory, or ultrasound facility without registration under the Act.

Penalties include imprisonment up to 3 years and fines up to INR 10,000 for a first offence, with harsher penalties for repeat offences and for medical practitioners, whose names are also struck off the register.

3. What the Act does not cover

Read carefully, the Act does not:

• Make it an offence for an Indian citizen to receive a legal medical procedure performed in another country under that country's law.
• Impose extraterritorial obligations on foreign clinics that do not operate in India and have no Indian registration.
• Restrict PGT-A performed for medically-indicated reasons (advanced maternal age, recurrent pregnancy loss, recurrent implantation failure, known genetic disorders).
• Prohibit patients from discussing their reproductive choices privately with their physicians in jurisdictions where such discussions are lawful.

4. The territorial question

Indian criminal and regulatory law is, with narrow exceptions, territorial: it regulates conduct that occurs within Indian territory or involves an Indian-registered facility. Extraterritorial jurisdiction exists for a specific, listed set of offences (terrorism, piracy, certain corruption offences) under Section 3 and Section 4 of the Indian Penal Code — but non-medical sex selection is not one of the offences to which extraterritorial jurisdiction has been extended.

This is not a novel or fringe reading. It reflects the mainstream view of Indian reproductive-law practitioners and has been the basis of the longstanding medical-tourism industry serving Indian patients from Thailand, Cyprus, the US, and Eastern Europe since the early 2000s.

The Pre-Conception and Pre-Natal Diagnostic Techniques Act is a territorial statute that regulates clinics, laboratories, and practitioners operating in India. Its criminal provisions do not attach to medical procedures performed outside India under the law of a foreign state. — Consensus reading among Indian medical-law practitioners.

5. Why PGT-A at IMC is not covered by the PCPNDT Act

For the Act to apply to a procedure at IMC Tashkent, three things would need to be simultaneously true:

1. IMC would need to be operating in India. It is not — IMC is a clinic incorporated and licensed in Uzbekistan, with no Indian branch, no Indian registration, and no Indian staff.
2. The procedure would need to be performed in India. It is not — the entire clinical pathway (stimulation monitoring in India is self-directed, with results shared for review; egg retrieval, ICSI, embryology, PGT-A biopsy, NGS sequencing, and embryo transfer all occur at IMC's laboratory in Tashkent).
3. The Act's criminal provisions would need to extend extraterritorially to conduct outside India. They do not.

Separately, the clinical pathway at IMC is preimplantation. PGT-A analyses chromosomes in a five-day-old blastocyst (a cluster of ~150 cells) before implantation. It is not pre-natal diagnosis (which the Act regulates). The Act addresses a foetus in a woman's uterus in India; preimplantation embryo testing in a foreign laboratory is clinically, legally, and ethically a different category.

6. The question for Indian doctors

Your Indian gynaecologist or fertility specialist is bound by the PCPNDT Act and by the National Medical Commission's code of conduct. Many are cautious about issuing written referrals for sex-selection cycles abroad, because the professional position (as opposed to the patient's statutory position) is less settled and varies across state medical councils.

This is not a barrier to your treatment. Indian patients routinely:

• Arrange their own preliminary bloodwork and ultrasounds in India through a private lab, interpreted by the foreign clinic.
• Obtain a fresh semen analysis privately.
• Manage stimulation medications with remote monitoring from the foreign clinic's physician.

At IMC we guide you through what preliminary testing you need, where in India to get it done, and how to share it with us — all without requiring your Indian doctor to be involved if you prefer.

7. Privacy and jurisdictional reality

Uzbekistan does not have an information-sharing treaty with India regarding fertility treatment records. Your records at IMC are stored on servers in Uzbekistan and in the European Union (where our processor services operate). We do not proactively share information with any Indian authority and we would not respond to informal enquiries.

That said: this is a jurisdictional observation, not a legal promise. We recommend you discuss any specific confidentiality concerns with your own counsel before deciding.

8. What to do if you are considering treatment abroad

Practical steps, in order:

1. Confirm your medical eligibility. Book a free 30-minute video consultation with IMC. We will review your history and tell you whether IVF with PGT-A is clinically appropriate — or whether a simpler path exists.
2. Get a written quote. In writing. In USD. All-inclusive.
3. Discuss with your own Indian counsel. If discretion matters to you, take the quote and this page to a lawyer you already trust.
4. Arrange preliminary tests in India. Hormone panel, pelvic ultrasound, semen analysis. Any reputable Indian private diagnostic lab can do these.
5. Plan two trips to Tashkent. 5–7 days for egg retrieval, 1–2 days 4–6 weeks later for embryo transfer.
6. Keep all documentation. Save written copies of the clinic's licence, your treatment plan, consent forms, and invoices. This is good medical practice and also useful if any question ever arises.

9. Sources & further reading

• Full text of the PCPNDT Act, 1994 (MoHFW, Government of India)
• Ministry of Health & Family Welfare, Government of India — periodic notifications and rules
• Indian Society for Assisted Reproduction — practice guidelines
• Indian Council of Medical Research (ICMR) — National Guidelines for Accreditation, Supervision and Regulation of ART Clinics
• Assisted Reproductive Technology (Regulation) Act, 2021 (India) — this Act regulates domestic ART and does not prohibit cross-border fertility treatment

Not legal advice. Educational only. Reviewed by the IMC medical leadership team, not by Indian counsel. For a binding opinion on your specific circumstances consult a qualified Indian advocate. Corrections welcomed at info@ivf.uz.

See also: Tashkent vs Dubai · Tashkent vs Thailand · Tashkent vs Cyprus · Cost calculator · Journey timeline